{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Zhang T"],"funding":["NIA NIH HHS","National Institute on Aging"],"pagination":["555-558.e1"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10089770"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["24(4)"],"pubmed_abstract":["<h4>Objectives</h4>More than two-thirds of assisted living (AL) residents have dementia or cognitive impairment and antipsychotics are commonly prescribed for behavioral disturbances. As AL communities are regulated by state-level policies, which vary significantly regarding the care for people with dementia, we examined how antipsychotic prescribing varied across states among AL residents with dementia.<h4>Design</h4>This was an observational study using 20% sample of national Medicare data in 2017.<h4>Setting and participants</h4>The study cohort included Medicare beneficiaries with dementia aged 65 years or older who resided in larger (≥25-bed) ALs in 2017.<h4>Methods</h4>The study outcome was the percentage of eligible AL person-months in which antipsychotics were prescribed for each s"],"journal":["Journal of the American Medical Directors Association"],"pubmed_title":["State Variation in Antipsychotic Use Among Assisted Living Residents With Dementia."],"pmcid":["PMC10089770"],"funding_grant_id":["R01AG065722","R21 AG061632","R01 AG057746","R21AG061632","P01 AG027296","RF1 AG061221","RF1AG061221","K08 AG071856","R24 AG064025","R01 AG065722","R24AG064025"],"pubmed_authors":["Shireman TI","Zhang T","Lo D","Varma H","Gerlach LB","Bynum JPW","Coe AB","Thomas KS","Joshi R","Zullo AR","Daiello LA"],"additional_accession":[]},"is_claimable":false,"name":"State Variation in Antipsychotic Use Among Assisted Living Residents With Dementia.","description":"<h4>Objectives</h4>More than two-thirds of assisted living (AL) residents have dementia or cognitive impairment and antipsychotics are commonly prescribed for behavioral disturbances. As AL communities are regulated by state-level policies, which vary significantly regarding the care for people with dementia, we examined how antipsychotic prescribing varied across states among AL residents with dementia.<h4>Design</h4>This was an observational study using 20% sample of national Medicare data in 2017.<h4>Setting and participants</h4>The study cohort included Medicare beneficiaries with dementia aged 65 years or older who resided in larger (≥25-bed) ALs in 2017.<h4>Methods</h4>The study outcome was the percentage of eligible AL person-months in which antipsychotics were prescribed for each s","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Apr","modification":"2025-04-04T19:58:12.74Z","creation":"2025-04-04T19:58:12.74Z"},"accession":"S-EPMC10089770","cross_references":{"pubmed":["36841263"],"doi":["10.1016/j.jamda.2023.01.014"]}}